Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

Nature Medicine

Volumn 18, Issue 12, 2012, Pages 1786-1796

  Broxmeyer, Hal E ^a   Hoggatt, Jonathan ^a,c   O'leary, Heather A ^a   Mantel, Charlie ^a   Chitteti, Brahmananda R ^b   Cooper, Scott ^a   Messina Graham, Steven ^a   Hangoc, Giao ^a   Farag, Sherif ^b   Rohrabaugh, Sara L ^a   Ou, Xuan ^a   Speth, Jennifer ^a   Pelus, Louis M ^a   Srour, Edward F ^a,b   Campbell, Timothy B ^a,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; DIPEPTIDYL PEPTIDASE IV; ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; STROMAL CELL DERIVED FACTOR 1;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; HEMATOPOIESIS; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; CELL LINE; CHEMOKINE CXCL12; DIPEPTIDYL PEPTIDASE 4; DNA PRIMERS; DRUG THERAPY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; IMMUNOPHENOTYPING; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RADIOTHERAPY; SIGNAL TRANSDUCTION;

MUS;

EID: 84870923584     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2991     Document Type: Article

References (55)

1. Broxmeyer, H.E. & Smith, F.O. Cord blood hematopoietic cell transplantation. in Thomas' Hematopoietic Cell Transplantation, 4th edn. (eds. Appelbaum, F.R., Forman, S.J., Negrin, R.S. & Blume, K.G.) 559-576 (Wiley-Blackwell, West Sussex, UK, 2009).
2. Shaheen, M. & Broxmeyer, H.E. The humoral regulation of hematopoiesis. in Hematology: Basic Principles and Practice, 5th edn. (eds. Hoffman, R. et al.) 253-275 (Elsevier Churchill Livingston, Philadelphia, 2009).
3. Rasmussen, H.B., Branner, S., Wiberg, F.C. & Wagtmann, N. Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat. Struct. Biol. 10, 19-25 (2003).
4. + progenitor cells. J. Immunol. 169, 7000-7008 (2002).
5. Christopherson, K.W., Hangoc, G., Mantel, C.R. & Broxmeyer, H.E. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305, 1000-1003 (2004).
6. Tian, C., Bagley, J., Forman, D. & Iacomini, J. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther. 13, 652-658 (2006).
7. Peranteau, W.H. et al. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 108, 4268-4274 (2006).
8. Wyss, B.K. et al. Enhanced homing and engraftment of fresh but not ex vivo cultured murine marrow cells in submyeloablated hosts following CD26 inhibition by Diprotin A. Exp. Hematol. 37, 814-823 (2009).
9. + cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice. Stem Cells Dev. 16, 347-354 (2007).
10. - human umbilical cord blood donor hematopoietic stem cells/ hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/ β2null immunodeficient mice. Stem Cells Dev. 16, 355-360 (2007).
11. + peripheral blood cells. Stem Cells Dev. 16, 361-370 (2007).
12. Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-848 (1999).
13. Campbell, T.B. & Broxmeyer, H.E. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation. Front. Biosci. 13, 1795-1805 (2008).
14. + cells: evidence for an autocrine/paracrine mechanism. Blood 99, 1117-1129 (2002).
15. Broxmeyer, H.E. et al. Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo. J. Immunol. 170, 421-429 (2003).
16. αi proteins and enhances engraftment of competitive, repopulating stem cells. J. Leukoc. Biol. 73, 630-638 (2003).
17. Lee, Y. et al. Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood 99, 4307-4317 (2002).
18. Piacibello, W. et al. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Blood 100, 4391-4400 (2002).
19. Broxmeyer, H.E. et al. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood. Blood 117, 4773-4777 (2011).
20. Carow, C.E. et al. Human multipotential progenitor cells (CFU-GEMM) have extensive replating capacity for secondary CFU-GEMM: An effect enhanced by cord blood plasma. Blood 81, 942-949 (1993).
21. Broxmeyer, H.E. et al. SDF-1/CXCL12 enhances in vitro replating capacity of murine and human multipotential and macrophage progenitor cells. Stem Cells Dev. 16, 589-596 (2007).
22. Broxmeyer, H.E. et al. The comparative effects in vivo of recombinant murine interleukin-3, natural murine colony stimulating factor-1 and recombinant murine granulocyte-macrophage colony stimulating factor on myelopoiesis in mice. J. Clin. Invest. 79, 721-730 (1987).
23. Broxmeyer, H.E. et al. Synergistic myelopoietic action in vivo of combinations of purified natural murine colony stimulating factor-1, recombinant murine interleukin-3, and recombinant murine granulocyte-macrophage colony stimulating factor administered to mice. Proc. Natl. Acad. Sci. USA 84, 3871-3875 (1987).
24. Broxmeyer, H.E. et al. Effects in vivo of purified recombinant human activin and erythropoietin, alone and in combination, in mice. Int. J. Hematol. 54, 447-454 (1991).
25. Kitamura, T. et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140, 323-334 (1989).
26. Woodcock, J.M. et al. A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common β-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J. Biol. Chem. 271, 25999-26006 (1996).
27. Woodcock, J.M. et al. Receptors of the cytokine superfamily: mechanisms of activation and involvement in disease. Baillieres Clin. Haematol. 10, 507-524 (1997).
28. Woodcock, J.M. et al. The functional basis of granulocyte-macrophage colony stimulating factor, interleukin-3 and interleukin-5 receptor activation, basic and clinical implications. Int. J. Biochem. Cell Biol. 31, 1017-1025 (1999).
29. Haman, A. et al. Molecular determinants of the granulocyte-macrophage colony- stimulating factor receptor complex assembly. J. Biol. Chem. 274, 34155-34163 (1999).
30. Niu, L. et al. Kinetic resolution of two mechanisms for high-affinity granulocyte-macrophage colony-stimulating factor binding to its receptor. Blood 94, 3748-3753 (1999).
31. Lopez, A.F. et al. Molecular basis of cytokine receptor activation. IUBMB Life 62, 509-518 (2010).
32. κB and induction of bcl-2. Blood 103, 820-827 (2004).
33. Hansen, G. et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 134, 496-507 (2008).
34. Hercus, T.R. et al. The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 114, 1289-1298 (2009).
35. Broxmeyer, H.E. Inhibition in vivo of mouse granulopoiesis by cell-free activity derived from human polymorphonuclear neutrophils. Blood 51, 889-901 (1978).
36. Chitteti, B.R. et al. Phenotypic characterization of hematopoietic stem cells. in Cord Blood: Biology, Transplantation, Banking, and Regulation (ed. Broxmeyer, H.E.) 75-86 (AABB Press, Bethesda, Maryland, 2011).
37. Waterstrat, A. et al. Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment. Blood 115, 408-417 (2010).
38. +. Exp. Hematol. 34, 1060-1068 (2006).
39. Kidd, S. et al. In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice. Exp. Hematol. 39, 580-590 (2011).
40. Zaruba, M.M. et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 4, 313-323 (2009).
41. + cell migration in myeloproliferative neoplasms. Cancer Res. 70, 3402-3410 (2010).
42. + cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6, 603-615 (2010).
43. Nie, Y., Han, Y.-C. & Zou, Y.-R. CXCR4 is required for the quiescence of primitive hematopoietic cells. J. Exp. Med. 205, 777-783 (2008).
44. Broxmeyer, H.E. et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201, 1307-1318 (2005).
45. Gotoh, A. et al. Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. Blood 88, 138-145 (1996).
46. + lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121, 295-306 (2005).
47. Bryder, D., Rossi, D.J. & Weissman, I.L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am. J. Pathol. 169, 338-346 (2006).
48. Chitteti, B.R. et al. Impact of interactions of cellular components of the bone marrow microenvironment on hematopoietic stem and progenitor cell function. Blood 115, 3239-3248 (2010).
49. Christensen, J.L. & Weissman, I.L. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98, 14541-14546 (2001).
50. Kiel, M.J., Yilmaz, O.H., Iwashita, T., Terhorst, C. & Morrison, S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121 (2005).
51. Kondo, M. et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759-806 (2003).
52. Osawa, M., Hanada, K., Hamada, H. & Nakauchi, H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-245 (1996).
53. Sitnicka, E. et al. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17, 463-472 (2002).
54. Mantel, C. et al. Cells enter a unique intermediate 4N stage, not 4N-G1, after aborted mitosis. Cell Cycle 7, 484-492 (2008).
55. Kajiyama, H. et al. Prolonged survival and decreased invasive activity attributable to dipeptidylpeptidase IV overexpression in ovarian carcinoma. Cancer Res. 62, 2753-2757 (2002).